S. Jevons

761 total citations
21 papers, 630 citations indexed

About

S. Jevons is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, S. Jevons has authored 21 papers receiving a total of 630 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 8 papers in Epidemiology and 7 papers in Molecular Biology. Recurrent topics in S. Jevons's work include Antifungal resistance and susceptibility (8 papers), Nail Diseases and Treatments (5 papers) and Carbohydrate Chemistry and Synthesis (3 papers). S. Jevons is often cited by papers focused on Antifungal resistance and susceptibility (8 papers), Nail Diseases and Treatments (5 papers) and Carbohydrate Chemistry and Synthesis (3 papers). S. Jevons collaborates with scholars based in United Kingdom, United States and Canada. S. Jevons's co-authors include Michael H. Tarbit, Michael Humphrey, Peter G. Barton, K. W. Brammer, J. T. B. Shaw, Diane P. Hanger, Geoffrey E. Gymer, David Cox, Brian A. Moore and M. S. Marriott and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

S. Jevons

21 papers receiving 556 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Jevons United Kingdom 10 312 259 114 91 48 21 630
Jackie L. Miller United States 13 446 1.4× 419 1.6× 156 1.4× 74 0.8× 95 2.0× 16 731
S. G. Jezequel United Kingdom 8 244 0.8× 126 0.5× 150 1.3× 108 1.2× 42 0.9× 12 596
Richard F. Hector United States 14 376 1.2× 375 1.4× 230 2.0× 54 0.6× 42 0.9× 19 799
S Elberg United States 12 216 0.7× 101 0.4× 121 1.1× 49 0.5× 20 0.4× 14 431
Kenneth Richardson United Kingdom 11 345 1.1× 244 0.9× 125 1.1× 56 0.6× 16 0.3× 15 717
Carolyn E. Hughes United States 11 351 1.1× 261 1.0× 43 0.4× 36 0.4× 60 1.3× 16 519
R Maller Sweden 14 161 0.5× 173 0.7× 91 0.8× 308 3.4× 43 0.9× 28 635
John Ling United States 16 347 1.1× 159 0.6× 217 1.9× 84 0.9× 23 0.5× 50 1.1k
George H. Warren United States 14 69 0.2× 120 0.5× 102 0.9× 97 1.1× 19 0.4× 40 578
V.B. Pikounis United States 6 519 1.7× 346 1.3× 210 1.8× 110 1.2× 33 0.7× 7 764

Countries citing papers authored by S. Jevons

Since Specialization
Citations

This map shows the geographic impact of S. Jevons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Jevons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Jevons more than expected).

Fields of papers citing papers by S. Jevons

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Jevons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Jevons. The network helps show where S. Jevons may publish in the future.

Co-authorship network of co-authors of S. Jevons

This figure shows the co-authorship network connecting the top 25 collaborators of S. Jevons. A scholar is included among the top collaborators of S. Jevons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Jevons. S. Jevons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hanger, Diane P., S. Jevons, & J. T. B. Shaw. (1988). Fluconazole and testosterone: in vivo and in vitro studies. Antimicrobial Agents and Chemotherapy. 32(5). 646–648. 40 indexed citations
2.
Shepherd, Richard, et al.. (1987). Effects of haemodialysis on taste for salt in relation to changes in blood constituents.. PubMed. 41(6). 441–51. 9 indexed citations
3.
4.
Shepherd, Richard, et al.. (1985). CHANGES IN SENSITIVITY AND PREFERENCES FOR SALT DURING DIALYSIS. View. 1 indexed citations
5.
Humphrey, Michael, S. Jevons, & Michael H. Tarbit. (1985). Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans. Antimicrobial Agents and Chemotherapy. 28(5). 648–653. 305 indexed citations
6.
Marriott, M. S., K. W. Brammer, J. M. Faccini, et al.. (1983). Tioconazole, a New Broad-Spectrum Antifungal Agent: Preclinical Studies Related to Vaginal Candidiasis. Gyn�kologisch-geburtshilfliche Rundschau. 23(1). 1–11. 5 indexed citations
7.
Halliwell, G., et al.. (1983). Tioconazole, a new imidazole-antifungal agent for the treatment of dermatomycoses. Antifungal and pharmacologic properties.. PubMed. 166 Suppl 1. 1–7. 9 indexed citations
8.
Marriott, M. S., et al.. (1983). Ticonazole, a New Imidazole-Antifungal Agent for the Treatment of Dermatomycoses. Dermatology. 166(Suppl. 1). 1–7. 14 indexed citations
9.
Jevons, S., et al.. (1983). Tioconazole in the Treatment of Vaginal Candidiasis. Gyn�kologisch-geburtshilfliche Rundschau. 23(1). 42–60. 8 indexed citations
10.
Jevons, S., et al.. (1983). Tioconazole in the Treatment of Fungal Infections of the Skin. Dermatology. 166(Suppl. 1). 20–33. 14 indexed citations
11.
Maesen, F. P. V., et al.. (1982). Combination of sulbactam pivoxyl and bacampicillin in acute exacerbations of chronic bronchitis. Journal of Antimicrobial Chemotherapy. 10(5). 445–452. 5 indexed citations
12.
Moore, Brian A., S. Jevons, & K. W. Brammer. (1979). Peptidoglycan Transpeptidase Inhibition in Pseudomonas aeruginosa and Escherichia coli by Penicillins and Cephalosporins. Antimicrobial Agents and Chemotherapy. 15(4). 513–517. 15 indexed citations
13.
Jevons, S., et al.. (1979). Antifungal Activity of Tioconazole (UK-20,349), a New Imidazole Derivative. Antimicrobial Agents and Chemotherapy. 15(4). 597–602. 60 indexed citations
14.
Brammer, K. W., et al.. (1979). Synthesis and antibacterial activity of 1-N-(1,3-dihydroxy-2-propyl)kanamycin B (UK-31,214).. The Journal of Antibiotics. 32(10). 973–977. 6 indexed citations
15.
Moore, Brian A., S. Jevons, & K. W. Brammer. (1979). Inhibition of Transpeptidase Activity in Escherichia coli by Thienamycin. Antimicrobial Agents and Chemotherapy. 15(6). 831–833. 6 indexed citations
16.
Jevons, S., et al.. (1978). In Vitro Studies with UK-18,892, a New Aminoglycoside Antibiotic. Antimicrobial Agents and Chemotherapy. 14(3). 277–280. 2 indexed citations
17.
Andrews, R. J., et al.. (1978). UK-18,892: Resistance to Modification by Aminoglycoside-Inactivating Enzymes. Antimicrobial Agents and Chemotherapy. 14(6). 846–850. 3 indexed citations
18.
Jevons, S., et al.. (1977). Synthesis and antibacterial activities of 1-N [(S)-.OMEGA.-amino-2-hydroxyalkyl] kanamycin a derivatives.. The Journal of Antibiotics. 30(10). 843–846. 13 indexed citations
19.
Barton, Peter G. & S. Jevons. (1971). Biochemistry of blood platelets. Interaction of activated factor X with platelets. Biochemistry. 10(3). 428–434. 36 indexed citations
20.
Barton, Peter G. & S. Jevons. (1970). Interactions of phosphatides with some paraffin-chain salts. Chemistry and Physics of Lipids. 4(3). 289–310. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jackie L. Miller Breakdown of academic impact, for papers by S. G. Jezequel Breakdown of academic impact, for papers by Richard F. Hector Breakdown of academic impact, for papers by S Elberg Breakdown of academic impact, for papers by Kenneth Richardson Breakdown of academic impact, for papers by Carolyn E. Hughes Breakdown of academic impact, for papers by R Maller Breakdown of academic impact, for papers by John Ling Breakdown of academic impact, for papers by George H. Warren Breakdown of academic impact, for papers by V.B. Pikounis
Rankless by CCL
2026